Information Technology Security Incident

Click here for a notice about a data privacy incident at Capital Health.

Who Can Benefit - What Can CyberKnife Treat

The CyberKnife® Robotic Radiosurgery System is a powerful noninvasive robotic machine that is used to treat cranial (head and neck) cancerous and noncancerous tumors as well as other tumors located throughout the body with extreme accuracy. The CyberKnife® System is an important tool for the physicians at Capital Health to use in treating tumors and other diseases. The system is a good alternative to surgery for the treatment of a variety of tumors including those which affect the prostate, lung, brain, spine, liver, pancreas and kidney. With each CyberKnife® case, the surgeon creates a treatment plan that will precisely deliver high doses of radiation to tumors without damaging surrounding tissues. This offers new hope to patients who have inoperable or multifaceted tumors that cannot be treated surgically, or for just a patient who may be looking for a nonsurgical option.

The following is a list of tumors that can be treated using the CyberKnife® System at Capital Health.

  • Cancers involving the brain
  • Malformations of blood vessels within the brain, such as arteriovenous malformations (AVMs)
  • Trigeminal neuralgia
  • Metastatic orbital tumors, orbital lymphomas and orbital inflammations.
  • Benign brain tumors, such as acoustic neuromas, meningiomas, pituitary adenomas, craniopharngiomal hemangioblastoma, schwannomas
  • Cancers involving the spine
  • Lung cancers
  • Pancreatic cancers
  • Kidney cancers
What are the benefits to the patient?
  • No pain
  • No incisions
  • No blood
  • No headframes
  • Submillimeter accuracy with less risk to healthy tissues
  • Improves quality of life during and after treatment
  • Takes place as an outpatient treatment
  • Fewer visits to the hospital
  • Short recovery period
  • Treatment option for patients who may have reached the maximum limits of conventional radiation therapy
  • Treatment option for patients considered inoperable by other surgery and stereotactic radiosurgery methods
  • Lower risk of complications when compared to other treatment options
  • Lower risk of infections